**UNITED
          STATES**
 **SECURITIES
          AND EXCHANGE COMMISSION**
 WASHINGTON,
          D.C. 20549
 
  **FORM
          10-QSB**
   **[X]
          QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE**
 **SECURITIES
          EXCHANGE ACT OF 1934**
  For
          the
          quarterly period ended **March
          31, 2007**
  OR
  **[
          ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE**
 **EXCHANGE
          ACT OF 1934**
  From
          the
          transition period from __________ to ___________
 Commission
          file number 000-30074
  **PAIVIS,
          CORP.**
 (Exact
          name of registrant as specified in its charter)
  **Nevada**
                **00030074**
                **86-0871787****(State
                    or other Jurisdiction**
                **(Commission
                    File**
                **(IRS
                    Employer****of
                    Incorporation)**
                **Number)**
                **Identification
                    No.)**
  **#400-3475
          Lenox Road, Atlanta Georgia 30326**
 (Address
          of principal executive offices) (Zip Code)
 
 Registrant’s
          telephone number, including area code: **(404)
          601-2885**
 
 Indicate
          by check mark whether the registrant (1) has filed all reports required
          by
          Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
          12 months (or for such shorter period of time that the registrant was required
          to file such reports), and (2) has been subject to such filing requirements
          for
          the past 90 days: Yes [X] No [ ]
  Indicate
          by check mark whether the registrant is a large accelerated filer, or an
          accelerated filer. See definition of "accelerated filer and large accelerated
          filer" in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated
          filer [
          ] Accelerated filer [ ] Non-accelerated filer [X]
  Indicate
          by check mark whether the registrant is a shell company (as defined in
          Rule
          12b-2 of the Exchange Act. Yes [ ] No [X]
  Indicate
          the number of shares outstanding of each of the issuer's classes of common
          stock, as of the latest practicable date. As of May 9, 2007
          30,663,838  shares
          of
          Common Stock of the issuer were issued and outstanding.
 
 -1-
 **PART
          I - FINANCIAL INFORMATION**
  **ITEM
          1. FINANCIAL STATEMENTS.**
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 
 **INTERIM
            CONSOLIDATED FINANCIAL STATEMENTS**
 
 
 **MARCH
            31, 2006**
 **(unaudited)**
 **(Stated
            in U.S. Dollars)**  -2-
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **INTERIM
            CONSOLIDATED BALANCE SHEETS**
 **(Stated
            in U.S. Dollars)**
  
 **March
                      31**
                    **2007**
                  
                  **September
                      30**
                    **2006****ASSETS****Current**Cash
                  
                  $
                  72,459
                  
                  $
                  88,678Goods
                      and Services Tax recoverable
                  
                  
                  2,790
                  
                  
                  7,453Accounts
                      Receivable
                  
                  
                  569,943
                  
                  
                  407,034Prepaid
                      expense, advances and other
                  
                  
                  38,598
                  
                  
                  28,009683,790
                  
                  
                  531,174**Capital
                      Assets**(Note 3)
                  
                  
                  60,144
                  
                  
                  100,961**Goodwill**
                  
                  
                  6,249,955
                  
                  
                  6,249,955**Minority
                      Interest in Subsidiaries**
                  
                  
                  (7,147)
                  
                  
                  
                  (7,147)$
                  6,986,742
                  
                  
                  6,874,943**LIABILITIES****Current**Accounts
                      payable and accrued liabilities
                  
                  $
                  5,429,300
                  
                  $
                  4,960,011Loans
                      and advances payable (Note 6)
                  
                  
                  2,869,956
                  
                  
                  2,655,121$
                  8,299,256
                  
                  $
                  7,615,132**STOCKHOLDERS’
                      DEFICIENCY****Capital
                      Stock**Authorized:125,000,000
                      common shares par value $0.0002 per share15,000,000
                      preferred shares, par value $0.0001 per shareIssued
                      and outstanding:30,797,076
                      common shares at March 31, 2007
                    and
                      30,558,352 at September 30, 2006
                  
                  
                  6,159
                  
                  
                  6,111792,592
                      Series A preferred sharesatMarch
                      31, 2007,
                    and
                      at September 30, 2006
                  
                  
                  79
                  
                  
                  793,000,750
                      Series B preferred sharesat
                      March 31, 2007,
                    and
                      at September 30, 2006
                  
                  
                  300
                  
                  
                  300Additional
                      paid-in capital
                  
                  
                  16,689,896
                  
                  
                  16,448,832**Accumulated
                      Deficit**
                  
                  
                  (18,008,948)
                  
                  
                  (17,195,512)(1,312,514)
                  
                  
                  (740,190)$
                  6,986,742
                  
                  
                  6,874,942
 
 The
            accompanying notes are an integral part of these consolidated financial
            statements.
  -3-
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **INTERIM
            CONSOLIDATED STATEMENTS OF OPERATIONS & DEFECIT**
 **(Stated
            in U.S. Dollars)**
 
 
 **THREE
                      MONTHS ENDED**
                      **March
                        31**
                  
                  **S****IX
                      MONTHS****ENDED**
                    **March
                      31****2007**
                  
                  **2006**
                  
                  **2007**
                  
                  **2006****Revenue**
                  
                  $
                  1,451,274
                  
                  $
                  1,872,999
                  
                  $
                  3,236,912
                  
                  $
                  3,139,336**Cost
                      of Sales**
                  
                  
                  1,141,482
                  
                  
                  1,509,672
                  
                  
                  2,513,072
                  
                  
                  2,694,814309,792
                  
                  
                  363,327
                  
                  
                  723,840
                  
                  
                  444,522**Expenses**Consulting
                  
                  
                  119,887
                  
                  
                  147,934
                  
                  
                  257,887
                  
                  
                  940,035Debt
                      retirement expense
                  
                  
                  
                  
                  
                  **-**
                  
                  
                  587,496
                  
                  
                  24,111
                  
                  
                  1,088,965Interest
                      expense
                  
                  
                  118,471
                  
                  
                  22,264
                  
                  
                  143,400
                  
                  
                  25,393Marketing
                  
                  
                  3,104
                  
                  
                  3,089
                  
                  
                  18,799
                  
                  
                  7,715Office,administration
                      and sundry
                  
                  
                  209,833
                  
                  
                  327,855
                  
                  
                  446,010
                  
                  
                  529,526Professional
                      fees
                  
                  
                  190,195
                  
                  
                  131,470
                  
                  
                  275,542
                  
                  
                  177,883Wages
                      and benefits
                  
                  
                  ****189,975
                  
                  
                  173,727
                  
                  
                  386,528
                  
                  
                  407,868816,465
                  
                  
                  1,393,864
                  
                  
                  1,537,277
                  
                  
                  3,177,385**Loss
                      Before The Following**
                  
                  
                  521,673
                  
                  
                  1,030,537
                  
                  
                  828,437
                  
                  
                  2,732,863**Minority
                      Interest In Loss of Subsidiary**
                  
                  
                  
                  
                  
                  **-**
                  
                  
                  15,390
                  
                  
                  
                  
                  
                  **-**
                  
                  
                  69,769**Loss
                      from Continuing Operations**
                  
                  
                  521,673
                  
                  
                  1,015,147
                  
                  
                  828,437
                  
                  
                  2,663,094**Net
                      Loss For The Period**
                  
                  $
                  521,673
                  
                  $
                  1,015,147
                  
                  $
                  828,437
                  
                  $
                  2,663,094**Net
                      Loss Per Share**,
                    Basic
                      and diluted
                  
                  $
                  0.02
                  
                  $
                  0.07
                  
                  $
                  0.03
                  
                  $
                  0.21**Weighted
                      Average Number Of Common Shares Outstanding**
                  
                  
                  30,797,076
                  
                  
                  16,607,306
                  
                  
                  30,691,563
                  
                  
                  12,874,129
 
 
 
 The
            accompanying notes are an integral part of these consolidated financial
            statements.
  -4-
  **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **INTERIM
            CONSOLIDATED STATEMENTS OF CASH FLOWS**
 **(Stated
            in U.S. Dollars)**
 
 
 **SIX
                      MONTHS ENDED**
                    **March
                      31****2007**
                  **2006****Cash
                      Flows From Operating Activities**Loss
                      for the period from continuing operations
                  $
                  (828,437)
                  $
                  (2,663,094)**Adjustments
                      To Reconcile Net Loss To Net Cash Used By Operating
                      Activities**Amortization
                  
                  40,817
                  
                  110,619Issue
                      of common stock for services
                  
                  217,000
                  
                  205,557Debt
                      Retirement Inducement Expense
                  
                  24,111
                  
                  985,956Change
                      in working capital items:Goods
                      and Services Tax recoverable
                  
                  4,663
                  
                  (12,960)Accounts
                      receivable
                  
                  (162,909)
                  
                  (91,669)Prepaid
                      expense
                  
                  (10,588)
                  
                  38,607Accounts
                      payable and accrued liabilities
                  
                  469,289
                  
                  782,223Other
                      Adjustments, net
                  
                  **-**
                  
                  70,066(231,054)
                  
                  (574,695)**Cash
                      Flows From Investing Activities**
                  
                  -
                  
                  --
                  
                  -**Cash
                      Flows From Financing Activities**Shares
                      issued for cash
                  
                  **-**
                  
                  41,661Loans
                      and advances payable
                  
                  214,835
                  
                  674,822214,835
                  
                  716,483**(Decrease)
                      Increase In Cash**
                  
                  (16,219)
                  
                  141,788**Cash,
                      Beginning Of Period**
                  
                  88,678
                  
                  8,240**Cash,
                      (Bank Indebtedness) End Of Period**
                  $
                  72,459
                  $
                  150,028**Supplemental
                      Disclosure of Non Cash Financing and Investing
                      Activities**Debt
                      issued for acquisition of investments
                  
                  -
                  
                  -Shares
                      issued for services
                  
                  **-**
                  
                  -Shares
                      issued for debt
                  
                  241,111
                  
                  993,624Shares
                      issued for acquisition of investments
                  
                  -
                  
                  -Shares
                      issued for deposit towards acquisition of investment
                  
                  -
                  
                  -**Supplemental
                      Disclosure Of Cash Flow Financing and Investing
                      Activities**Interest
                      paid
                  $
                  231
                  $
                  -Income
                      taxes paid
                  
                  -
                  
                  -
 
 The
            accompanying notes are an integral part of these consolidated financial
            statements.
 
  -5-
  
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **NOTES
            TO INERIM CONSOLIDATED FINANCIAL STATEMENTS**
 
 **March
            31, 200** **7**
 **(Unaudited)**
 **(Stated
            in U.S. Dollars)**
 
 **1.**  **NATURE
            OF OPERATIONS**
 
 Organization
 
 The
            Company was incorporated in the State of Nevada, U.S.A., on April 28,
            1997.
 
 On
            April
            21, 2006, PAIVIS, Corp. (f/k/a APO Health, Inc)., a Nevada corporation
            (“APO”),
            entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”)
            with APO Health Acquisition Corp, Inc., a Nevada corporation and wholly-owned
            subsidiary of APO (“APO Acquisition”), and Jupiter Global Holdings, Corp., a
            Nevada corporation (“Jupiter”). As per the Merger Agreement provided that upon
            the terms and subject to the conditions set forth in the Merger Agreement,
            APO
            Acquisition merged with and into Jupiter, with Jupiter being the surviving
            corporation and a wholly-owned subsidiary of APO. Historical Financial
            Statements presented are those of Jupiter Global Holdings Corp.
 
 Business
            Activities
 
 The
            Company’s business operations consist of telecommunications switching services.
            The Company is a facility-based wholesale telecommunications carrier
            that
            delivers many application/value-added services within the prepaid services
            space. The Company operates and maintains a robust switching facility,
            offering
            over 16,000 ports with connectivity to most of the tier 1 carriers in
            the US and
            manages an extensive international (A-Z) network.  In addition to the
            wholesale business, The Company maintains a large retail distribution
            network
            for direct to consumer services. The Company’s products are sold through
            approximately 3,000 retail outlets in the United States and our distribution
            is
            rapidly expanding.
 
 Going
            Concern
 
 Since
            inception, the Company has suffered recurring losses, net cash outflows
            from
            operations and, at March 31, 2007, has accumulated a deficit of $18,023,948
            and
            a working capital deficiency of $7,630,466. The Company expects to continue
            to
            incur substantial losses to continue the growth of its business. Since
            its
            inception, the Company has funded operations through common stock issuances
            and
            related party loans in order to meet its strategic objectives. Management
            believes that sufficient funding will be available to meet its business
            objectives, including anticipated cash needs for working capital, and
            is
            currently evaluating several financing options. However, there can be
            no
            assurance that the Company will be able to obtain sufficient funds to
            continue
            the business growth of and, if successful, to grow the sale of its products
            and
            services under development. As a result of the foregoing, there exists
            substantial doubt about the Company’s ability to continue as a going concern.
            These consolidated financial statements do not include any adjustments
            that
            might result if the Company is unable to realize its assets and settle
            its
            obligations in the normal course of business.
  -6-
  
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **NOTES
            TO INERIM CONSOLIDATED FINANCIAL STATEMENTS**
 
 **March
            31, 200** **7**
 **(Unaudited)**
 **(Stated
            in U.S. Dollars)**
 
 **1.**  **NATURE
            OF OPERATIONS (cont)**
 
 
 The
            accompanying unaudited interim consolidated financial statements of the
            Company
            have been prepared in accordance with generally accepted accounting principles
            in the United States of America. Because a precise determination of many
            assets
            and liabilities is dependent upon future events, the preparation of consolidated
            financial statements for a period necessarily involves the use of estimates
            which have been made using careful judgment. These unaudited interim
            consolidated financial statements should be read in conjunction with
            the
            financial statements for the 12 months ending September 30, 2006 in the
            Form
            10-KSB as filed with the Securities and Exchange Commission.
 
 The
            consolidated financial statements have, in management’s opinion, been properly
            prepared within reasonable limits of materiality and within the framework
            of the
            significant accounting policies summarized below:
 
 Consolidation
 
 These
            consolidated financial statements include the accounts of the Company,
            its 100%
            owned subsidiaries, Jupiter Global Holdings, Corp., MACRO Communications,
            Inc.,
            Trucall Solutions Inc., RRUN Labs Incorporated, LIVESTAR Entertainment
            Canada
            Inc., 1615496 Ontario Ltd., 1614718 Ontario Inc., LIVESTAR Entertainment
            Establishment Ltd., LIVESTAR Entertainment Events International Inc.,
            its 67%
            owned subsidiary, RAHX, Inc., and its 51% owned subsidiary LIVE & Cool One,
            Inc..
 
 **2.**  **SIGNIFICANT ACCOUNTING POLICIES**
 
 a)
                Income
                    Taxes 
 The
            Company has adopted Statement of Financial Accounting Standards No. 109
            -
“Accounting for Income Taxes” (SFAS 109). This standard requires the use of an
            asset and liability approach for financial accounting and reporting on
            income
            taxes. If it is more likely than not that some portion or all of a deferred
            tax
            asset will not be realized, a valuation allowance is recognized.
 
 b)
                Amortization 
 Capital
            assets are being amortized over their estimated useful lives on the
            straight-line basis at the following rates:
 
 Computer
                      equipment
                  3
                      yearsTelecom
                      Equipment
                  5
                      years
 
  -7-
  
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **NOTES
            TO INERIM CONSOLIDATED FINANCIAL STATEMENTS**
 
 **March
            31, 200** **7**
 **(Unaudited)**
 **(Stated
            in U.S. Dollars)**
 
 **2.**  **SIGNIFICANT ACCOUNTING POLICIES (cont)**
 
 c)
                Stock
                    Based Compensation 
 The
            Company accounts for stock based employee compensation arrangements in
            accordance with the provisions of the Statement of Financial Accounting
            Standards No. 123 - “Accounting for Stock Based Compensation” (SFAS No. 123).
            Under SFAS No.123, compensation expense is recognized based on the Fair
            Market
            Value of the options granted.
 
 d)
                Financial
                    Instruments 
 The
            Company’s financial instruments consist of cash, accounts receivable, Goods and
            Services Tax recoverable, accounts payable and accrued liabilities, and
            loans
            and advances payable.
  Unless
            otherwise noted, it is management’s opinion that this Company is not exposed to
            significant interest or credit risks arising from these financial instruments.
            The fair value of these financial instruments approximates their carrying
            values, unless otherwise noted.
 
 e)
                Net
                    Loss Per Share 
 Basic
            earnings per share is computed by dividing income available to common
            shareholders by the weighted average number of common shares outstanding
            in the
            period. Diluted earnings per share takes into consideration common shares
            outstanding (computed under basic earnings per share) and potentially
            dilutive
            common stock equivalents including warrants, options and convertible
            instruments. Diluted loss per share equals loss per share as the exercise
            of any
            common stock equivalents would be anti-dilutive.
 
 f)
                Foreign
                    Currency Translation 
 Transaction
            amounts denominated in foreign currencies are translated at exchange
            rates
            prevailing at transaction dates. Carrying values of monetary assets and
            liabilities are adjusted at each balance sheet date to reflect the exchange
            rate
            at that date. Non-monetary assets and liabilities are translated at the
            exchange
            rate on the original transaction date. Gains and losses from restatement
            of
            foreign currency monetary and non-monetary assets and liabilities are
            included
            in the statements of operations. Revenues and expenses are translated
            at the
            rates of exchange prevailing on the dates such items are recognized in
            the
            statements of operations.
  -8-
  
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **NOTES
            TO INERIM CONSOLIDATED FINANCIAL STATEMENTS**
 
 **March
            31, 200** **7**
 **(Unaudited)**
 **(Stated
            in U.S. Dollars)**
 
 **2.**  **SIGNIFICANT ACCOUNTING POLICIES (cont)**
 
 g)
                Revenue
                    Recognition 
 The
            Company recognizes revenue upon the sale and activation of a telephone
            calling
            card.
 
 **3.**
                  **CAPITAL
                      ASSETS**
 
 **March
                      31, 2007****COST**
                  **ACCUMULATED**
                  **NET
                      BOOK****AMORTIZATION**
                  **VALUE**Computer
                      equipment
                  $
                  18,016
                  $
                  17,647
                  $
                  368Telecom
                      equipment
                  
                  1,063,065
                  
                  1,003,289
                  
                  59,776$
                  1,081,081
                  
                  1,020,937
                  
                  60,144**March
                      31, 2006****COST**
                  **ACCUMULATED**
                  **NET
                      BOOK****AMORTIZATION**
                  **VALUE**Computer
                      equipment
                  $
                  18,016
                  $
                  16,473
                  **$**
                  1,543Telecom
                      equipment
                  
                  1,063,065
                  
                  861,400
                  
                  201,665$
                  1,081,081
                  
                  877,873
                  
                  203,208
 
 At
            March 31, 2007 (March 31, 2006) the net book value of equipment serving
            as
            collateral for equipment and bank borrowings is $60,144 ($203,208).
 
 **4.**  **OBLIGATIONS
            UNDER CAPITAL LEASES**
 
 Included
            within Loans & Advances Payables is equipment under capital leases at March
            31, 2007 and 2006 as follows:
 
 **March
                      31**
                    **2007**
                  **March
                      31**
                    **2006**Cost
                  $
                  -
                  $
                  923,572Less
                      Accumulated Depreciation
                  
                  -
                  
                  745,099Net
                      Book Value
                  
                  -
                  
                  178,473
 
 As
            at March 31, 2007, there are no more capital leases outstanding with
            the
            Company.
 
  -9-
  
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **NOTES
            TO INERIM CONSOLIDATED FINANCIAL STATEMENTS**
 
 **March
            31, 200** **7**
 **(Unaudited)**
 **(Stated
            in U.S. Dollars)**
 
 **5.**  **CONTINGENCIES**
 
 **Litigation**
 
 The
            Company is in settlement negotiations with a telecom carrier who has
            filed
            proceedings for delinquent payments. Amounts payable to this vendor have
            been
            recorded in accounts payable as at March 31, 2007. Management believes
            the
            ultimate disposition of these matters will not have a material adverse
            impact on
            the operations or financial condition of the Company.
 
 The
            Company is a defendant in a lawsuit filed by a former service provider.
            Management believes the claim is without merit and that any potential
            judgement
            against the Company would not have a material adverse impact on the operations
            or financial condition of the Company. Accordingly no contingent liability
            has
            been accrued.
 
 **6.**  **LOANS
            AND ADVANCES**
 
 All
            loans
            and advances payable are past due or are repayable within one year, unsecured,
            not convertible into the Company stock. At the period ending March 31,
            2007,
            loans and advances consisted of:
 
 **March
                      31**
                    **2007**
                  **March
                      31**
                    **2006**Loans
                      & Advances-
                      past due
                  $
                  1,208,192
                  $
                  1,208,192-
                      due within one year
                  
                  1,661,764
                  
                  717,066Total
                      Loans & Advances Payable
                  $
                  2,869,956
                  $
                  1,925,258
 
 The
            past
            due loans and advances were issued in the period ended March 31, 2007,
            and the
            holders have not demanded payment.
 
 
  -10-
  
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **NOTES
            TO INERIM CONSOLIDATED FINANCIAL STATEMENTS**
 
 **March
            31, 2007**
 **(Unaudited)**
 **(Stated
            in U.S. Dollars)**
 
 **6.**  **LOANS
            AND ADVANCES** **(cont)**
 
 Of
            the
            Loans and Advances, additional details have been listed below:
 
 **March
                      31**
                    **2007**
                  **March
                      31**
                    **2006**Bears
                      no interest
                  $
                  418,565
                  $
                  418,565Bears
                      no interest, paid Loan fee of $176,957and $ 165,958
                  
                  1,727,504
                  
                  797,696Bears
                      an interest rate of 8 %
                  
                  135,875
                  
                  120,985Bears
                      an interest rate of 5%
                  
                  116,320
                  
                  116,320Bears
                      an interest rate 8.8%
                  
                  471,692
                  
                  471,692Total
                      Loan & Advances Payable
                  $
                  2,869,956
                  $
                  1,925,258
 
 **7.**  **WARRANTS
            OUTSTANDING**
 
 As
            at
            March 31, 2007, share purchase warrants were outstanding for the purchase
            of
            common shares as follows:
 
 **NUMBER**
                    **OF
                      SHARES**
                  
                  **PRICE**
                    **PER
                      SHARE**
                  **EXPIRY
                      DATE**2,250,000
                  
                  $
                  1.50
                  June
                      1, 2009200,000
                  
                  $
                  1.50
                  June
                      1, 20092,450,000
 
 -11-
 
 **PAIVIS,
            CORP.**
 **(Formerly
            APO Health, Inc.)**
 
 **NOTES
            TO INERIM CONSOLIDATED FINANCIAL STATEMENTS**
 
 **March
            31, 200** **7**
 **(Unaudited)**
 **(Stated
            in U.S. Dollars)**
 
 **7.**  **WARRANTS
            OUTSTANDING (cont)**
 
 A
            summary
            of the changes in shares which may be purchased on exercise of warrants
            for the
            year ended March 31, 2007is presented below:
 
 **NUMBER**
                    **OF**
                    **SHARES**
                  **WEIGHTED**
                    **AVERAGE**
                    **EXERCISE**
                    **PRICE**Balance,
                      September 30, 2005
                  0Granted
                  2,450,000
                  
                  1.50Balance,
                      September 30, 2006
                  2,450,000
                  $
                  1.50No
                      Warrant Activity
                  0Balance,
                      March 31, 2007
                  2,450,000
                  $
                  1.50
 
 At
            March
            31, 2007a total of 2 warrants remain issued and outstanding, and underlie
            the
            shares listed in the table above.
 
 **8.**  **BUSINESS
            SEGMENTS**
 
 The
            Company currently operates in a single business segment, “Telephone
            Communications”, in a single geographic area, North America.
 
 **9.**  **RELATED
            PARTY TRANSACTIONS**
 
 a)
                Included
                    in accounts payable at March 31, 2007 is $755,637 (2006 - $494,600)
                    owing
                    to directors or companies controlled by
                    directors. 
 b)
                Included
                    in loans and advances payable at March 31, 2007 is $113,224 (2006
                    -
                    $291,225) owing to directors or a companies controlled by
                    directors. 
 c)
                During
                    the period ended March 31, 2007, the Company incurred $180,000
                    (2006-
                    $180,000) in consulting expense to companies controlled by
                    directors. 
 d)
                During
                    the period ended March 31, 2007, the Company incurred no expenses
                    (2006 -
                    $27,226) in administration, office, and equipment rental expenses
                    with
                    companies controlled by directors. 
 -12-
  **ITEM
          2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
          OF
          OPERATIONS.**
  **FORWARD-LOOKING
          STATEMENTS**
 
 Except
          for the historical information and discussions contained herein, statements
          contained in this Form 10-QSB may constitute forward-looking statements
          within
          the meaning of the Private Securities Litigation Reform Act of 1995. These
          statements involve a number of risks, uncertainties and other factors that
          could
          cause actual results to differ materially, including any projections of
          earnings, revenues, or other financial items; any statements of the plans,
          strategies, and objectives of management for future operation; any statements
          concerning proposed new products, services, or developments, any statements
          regarding future economic conditions or performance, statements of belief,
          statements of assumptions underlying any of the foregoing and other risks,
          uncertainties and factors discussed elsewhere in this Form 10-QSB or in
          the
          Company’s other filings with the Securities and Exchange Commission
 
 ***OVERVIEW***
  Paivis
          Corp.’s (“Paivis”, the “Company” or the “Registrant”) business operations
          commenced June 2000 and consist of telecommunications switching services.
          Paivis
          is facility-based wholesale telecommunications carrier that delivers many
          application/value-added services within the prepaid services space. The
          Company
          operates and maintains a robust switching facility, offering over 16,000
          ports
          with connectivity to most of the tier 1 carriers in the US and manages
          an
          extensive international (A-Z) network.  In addition to the wholesale
          business, Paivis maintains a large retail distribution network for direct
          to
          consumer services. Our products are sold through approximately 3,000 retail
          outlets in the United States and our distribution is rapidly expanding.
  The
          future growth of the Company is focused on implementing a plan of growth
          of our
          current business operations, and also growth through acquisitions. The
          Company
          is currently in discussions with several acquisition candidates.
  The
          following analysis discusses changes in the financial condition and results
          of
          operations at and for the three months periods ended on March 31, 2007
          and March
          31, 2006 and should be read in conjunction with our unaudited consolidated
          financial statements and the notes thereto. This subsection of MD&A is an
          overview of the important factors that management focuses on in evaluating
          our
          businesses, financial condition and operating performance, our overall
          business
          strategy and our earnings, if any, for the periods covered.
 
 ***OUR
          COMPANY HISTORY***
  Paivis,Corp,
          (formerly known as APO Health, Inc., Internetfinancialcorp.com, Caribbean
          Ventures Inc., and Dom Caribe Ltd.) was originally incorporated in the
          State of
          Nevada in April 1997. From mid 2001 until mid 2006, our predecessor, APO
          Health,
          Inc. was primarily engaged in the business of wholesale medical products.
          In May
          of 2006 the Registrant completed a Merger transaction (details below) where
          effectively Jupiter Global Holdings, Corp. became a wholly owned subsidiary
          of
          the Registrant. With completion of the Merger transaction the Registrant
          effected a sale of the APO Health subsidiary (“APO Health NY”) responsible for
          the business of wholesale medical products (details below). Furthermore,
          due to
          the Merger transaction and subsequent sale of APO Health NY the Registrants
          business will be primarily engaged in the core operating business of Jupiter,
          prepaid technologies and telecom-based services.
 
 Headquartered
          in Atlanta, Georgia, the Company is publicly traded and Paivis, Corp. presently
          conducts its business operations through its operating subsidiaries located
          in
          the United States.
 
 ***OUR
          BUSINESS OPERATIONS***
 
 Paivis’
          present business operations commenced June 2000 and involve providing prepaid
          long distance services. We generate revenues through the domestic and foreign
          sale of a variety of telecommunications products and services, such as
          prepaid
          calling cards, prepaid wireless service and international wholesale termination.
          Our products are sold through approximately 3,000 retail outlets in the
          United
          States and our distribution is rapidly expanding.
 
 The
          discussion below of our performance is based upon our consolidated financial
          statements as of and for the three months periods ended March 31, 2007
          and March
          31, 2006.
 -13-
 **RESULTS
          OF OPERATIONS**
 FOR
            THE
            THREE MONTH PERIOD ENDED MARCH 31, 2007
  For
          the
          three month period ended March 31, 2007, the Company earned revenues of
          $
          1,451,274. The revenues were from sales of airtime related to telephone
          calling
          cards.
  During
          the three month period ended March 31, 2007, the Company incurred operational
          expenses of $816,465. These operating expenses included: consulting fees
          of
          $119,887, wages and benefits of $189,975, and professional fees of $190,195
          for
          the three month period ending March 31, 2007.
  During
          the three month period ended March 31, 2007, the Company incurred a net
          loss
          from operations of $521,673.
  FOR
          THE
          THREE MONTH PERIOD ENDED MARCH 31, 2007, COMPARED TO THE THREE MONTH PERIOD
          ENDED MARCH 31, 2006.
  For
          the
          three month period ended March 31, 2007, the Company earned revenues of
          $1,451,274 as compared to revenues of $1,872,999 for the same period ended
          March
          31, 2006. The changes in revenues in 2007 are a result of the Company’s
          continued efforts to restructure its business and product
          offerings.
  For
          the
          three month period ended March 31, 2007, the Company incurred operational
          expenses of $816,465 as compared to $1,393,864 during the same period in
          the
          previous year. These operating expenses included: consulting fees of $119,887
          and $147,934, wages & benefits of $189,975 and $173,727, and professional
          fees of $190,195 and $131,470 for the three month period ended March 31,
          2007
          and 2006, respectively. The variation in expenses from March 31, 2007 as
          compared to the same period in the previous year is due to the continued
          efforts
          to restructure its business operations and reduction of debt.
  The
          Company incurred a net loss from operations of $521,673 for the fiscal
          quarter
          ended March 31, 2007, as compared to $1,015,147 for the same period in
          the
          previous year.
 
 SIGNIFICANT
          ACCOUNTING POLICIES
 
 Our
          significant accounting policies have been outlined in our 10KSB filing
          for the
          year ending September 30, 2006, and are thus incorporated by reference.
          We have
          had no significant changes to our accounting policies or assumptions in
          the
          three month period ending March 31, 2007.
 
 **Liquidity
          and Financial Condition As Of March 31, 2007**
  We
          had
          cash-on hand totaling $ 72,459 as of March 31, 2007.
 -14-
 We
          believe that our currently available working capital provided by operating
          activities may be insufficient to meet our operations at our current level
          and
          working capital and capital expenditure needs over the next 12 months.
          Our
          future capital requirements will depend on many factors, including our
          rate of
          revenue growth, the expansion of our marketing and sales activities, the
          timing
          and extent of spending to support product development efforts and expansion
          into
          new territories, the timing of introductions of new products or services,
          the
          timing of enhancements to existing products and services and the timing
          of
          capital expenditures. Also, we may make investments in, or acquisitions
          of,
          complementary businesses, services or technologies which could also require
          us
          to seek additional equity or debt financing. To the extent that available
          funds
          are insufficient to fund our future activities, we may need to raise additional
          funds through public or private equity or debt financing. Additional funds
          may
          not be available on terms favorable to us or at all.
 
 Management
          plans on initiating a series of securities offerings to raise the investment
          capital needed to meet our acquisition and development plans. Paivis hopes
          to
          secure the financing to satisfy the capital needs through the execution
          of
          various funding methods, primarily financing through, private placement
          investments or debt financing. Paivis hopes to achieve this by securing
          relationships with accredited individual investors, investment bankers,
          venture
          capitalists, hedge funds and/or finance investment advisors that have the
          experience and relationships to aid Paivis with its capital raising efforts.
          The
          source of the capital may be comprised of a mix of principal shareholders,
          private investors and venture capital companies.
 
 If
          needed
          capital investment for our acquisitions or developments is not available,
          in
          whole or in part, we intend to delay the implementation plan regarding
          our
          acquisitions or development plans until sufficient investment capital becomes
          available. We cannot give any assurances that we will raise sufficient
          investment capital to meet the business plan. In addition to delays to
          the
          implementation plan regarding our acquisition or development plans due
          to
          insufficiency of investment capital, we may suffer other consequences,
          including
          but not limited to the following: We may have to significantly alter the
          scope
          of our business plan and subsequent capital requirements; We may have to
          suspend
          or discontinue operations of one or more of our business units or; we may
          have
          to suspend or discontinue operations of the Company if we become insolvent
          as a
          result.
 
 Until
          planned acquisitions and operating activities begin to produce significant
          revenues and subsequent positive cash flow, we will be reliant on capital
          received from private placements, loans, and the exercise of options and
          warrants.
 -15-
  
 **OFF-BALANCE
          SHEET ARRANGEMENTS**
  The
          Company does not have any off-balance sheet arrangements that are likely
          to have
          a current or future effect on the Company's financial condition, revenues
          or
          expenses, results of operations or capital resources.
  **ITEM
          3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
          RISK.**
  **ITEM
          4. CONTROLS AND PROCEDURES.**
  As
          of the
          end of the period covered by this report the Company conducted an evaluation,
          under the supervision and with the participation of its principal executive
          officer and principal financial officer, of the Company's disclosure controls
          and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the
          Exchange
          Act). Based upon this evaluation, the Company's principal executive officer
          and
          principal financial officer concluded that the Company's disclosure controls
          and
          procedures are effective to ensure that information required to be disclosed
          by
          the Company in the reports that it files or submits under the Exchange
          Act is:
          (1) accumulated and communicated to the Company's management, including
          its
          principal executive officer and principal financial officer, as appropriate
          to
          allow timely decisions regarding required disclosure; and (2) recorded,
          processed, summarized and reported, within the time periods specified in
          the
          Commission's rules and forms. There was no change in the Company's internal
          controls or in other factors that could affect these controls during the
          Company's last fiscal quarter that has materially affected, or is reasonably
          likely to materially affect, the Company's s internal control over financial
          reporting.
  **PART
          II - OTHER INFORMATION**
  **ITEM
          1. LEGAL PROCEEDINGS.**
 
 On
          February 15, 2007, the Registrant filed a lawsuit in Arapahoe County District
          Court, Colorado, against John J. Donnelly and Executive Transfer & Registrar
          Inc. (“Executive Registrar”), the Registrant’s former stock transfer agent. We
          requested the court to issue a temporary restraining order and grant a
          preliminary injunction to compel Executive Registrar and Mr. Donnelly to
          transfer all of our stock books and records to our newly appointed stock
          transfer agent, Corporate Stock Transfer, Inc., as required by rules and
          procedures mandated by the U.S. Securities and Exchange Commission, and
          to
          compel Executive Registrar to file it’s termination notice with the Depository
          Trust Company as required by the U.S. Securities and Exchange Commission.
 
 On
          February 20, 2007, the court approved a consent order entered into between
          the
          Registrant and Executive Transfer that compels Executive Transfer to immediately
          cease and desist issuing any shares of our common stock, and within 10
          days,
          deliver a certified shareholders’ list to Corporate Stock Transfer, Inc. and
          also to formally notify Depository Trust Company in writing of the termination
          of Executive Registrar as our stock transfer agent.
 
 During
          the period covered by this report, the Registrant’s subsidiary, Macro
          Communications, Inc. (“Macro”) was notified of the commencement of garnishment
          proceedings supplemental to the Final Judgment entered on March 5, 2007,
          in the
          lawsuit previously filed against Macro by iBasis, Inc., in the Superior
          Court—Gwinnett County, Georgia, File No.: 06-A-09136-8. A Summons of Garnishment
          was issued by that same court on April 2, 2007 asserting that Macro was
          indebted
          to iBasis, Inc. in the sum of $320,851.72 at that date. The Registrant
          does not
          contest the validity of the underlying Final Judgment that was entered
          in favor
          of iBasis, Inc.
 -16-
 **ITEM
          2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
          PROCEEDS.**
  In
          May
          2007, the Board of Directors approved the issuance of 300,000 common shares
          for
          a consultant to provide investor relations services to the Company. This
          issuance was exempt from registration requirements under Section 4(2) of
          the
          Securities Act of 1933, as amended, as the issuance did not involve any
          public
          offering of the registrant’s securities.
  **ITEM
          3. DEFAULTS UPON SENIOR SECURITIES.**
  None.
  **ITEM
          4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.**
  None.
  **ITEM
          5. OTHER INFORMATION.**
 
 Additional
          Information Regarding The Company change of Transfer Agents
 
 On
          April
          17, 2007, Corporate Stock Transfer, Inc. notified us that it had taken
          possession of the necessary stock transfer records from Executive Transfer.
 In
          May,
          2007, Corporate Stock Transfer and the registrant were approved by the
          Depository Trust Company and
          Corporate Stock
          Transfer reported to us that it began to make significant headway in completing
          open deliveries of our common stock and the exchange of shares of our common
          stock for the outstanding shares of Jupiter Global Holding Corp. (“Jupiter”), as
          required in our merger with Jupiter.
 
 As
          of the
          date of this report the Company, specifically Paivis management, asks for
          all
          new shareholders from Jupiter to notify their broker dealer to contact
          the new
          stock transfer agent to aid in the expediting of the delivery of their
          Paivis
          certificates. A number of broker dealers have not contacted the new transfer
          agent despite communication that has been made on behalf of the Company
          or have
          contacted the new transfer agent but have not submitted the list of beneficial
          holders. Any further delays in communication and cooperation from the
          broker-dealers representing Jupiter shareholders may result in additional
          setbacks in issuing replacement Paivis shares to the shareholders of those
          broker-dealers.
 
 Any
          shares of our common stock issued and delivered after December 29, 2006
          counter-signed by Executive Registrar are deemed to be unauthorized and
          will be
          canceled when presented to the new stock transfer agent, as that is the
          effective date of termination of Executive Registrar.
 
 The
          Company is working closely with the new transfer agent to execute all open
          matters related to the issuance of certificates and expects to be complete
          in
          the upcoming weeks.
 -17-
 
 **ITEM
          6. EXHIBITS.**
  31.1
          Certification by Gregory Bauer, Chief Executive Officer and Principal Financial
          Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of
          2002.
  32.1
          Certification by Gregory Bauer, Chief Executive Officer and Principal Financial
          Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of
          2002.
 -18-
 **SIGNATURES**
  Pursuant
          to the requirements of the Securities Exchange Act of 1934, the registrant
          has
          duly caused this report to be signed on its behalf by the undersigned thereunto
          duly authorized.
 **PAIVIS,
                    CORP.**Date: May
                    21, 2007
                By:
                /s/ 
                    Gregory BauerGregory
                    Bauer, Chief Executive
                  Officer,
                    Acting Principal
                  Accounting
                    Officer
 -19-